J. Charles

8.5k total citations · 1 hit paper
60 papers, 1.1k citations indexed

About

J. Charles is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, J. Charles has authored 60 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Immunology, 23 papers in Oncology and 13 papers in Molecular Biology. Recurrent topics in J. Charles's work include Immunotherapy and Immune Responses (25 papers), T-cell and B-cell Immunology (14 papers) and CAR-T cell therapy research (13 papers). J. Charles is often cited by papers focused on Immunotherapy and Immune Responses (25 papers), T-cell and B-cell Immunology (14 papers) and CAR-T cell therapy research (13 papers). J. Charles collaborates with scholars based in France, United States and Belgium. J. Charles's co-authors include M.‐T. Leccia, Caroline Aspord, Joël Plumas, Laurence Chaperot, Stéphane Mouret, Florence de Fraipont, Dimitri Salameire, Benoît Busser, I. Templier and Nathalie Bendriss‐Vermare and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

J. Charles

54 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

MCT1 lactate transporter blockade re-invigorates anti-tumor immunity through metabolic rewiring of dendritic cells in melanoma

2025 18 citations Stéphane Mouret, Mylène Pezet et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. Charles France	19	651	475	262	72	67	60	1.1k
Scott A. Gerber United States	17	483 0.7×	473 1.0×	185 0.7×	88 1.2×	15 0.2×	43	1.0k
Neely Atkinson United States	14	277 0.4×	260 0.5×	150 0.6×	156 2.2×	5 0.1×	19	1.0k
Hiroshi Nishio Japan	19	184 0.3×	336 0.7×	169 0.6×	218 3.0×	4 0.1×	67	936
Marion Larroque France	11	241 0.4×	152 0.3×	483 1.8×	68 0.9×	4 0.1×	21	835
Yang Cao China	19	267 0.4×	638 1.3×	277 1.1×	58 0.8×	1 0.0×	79	1.1k
A. Glaser Germany	13	542 0.8×	167 0.4×	207 0.8×	28 0.4×	20 0.3×	22	889
Thomas Hager Germany	21	90 0.1×	371 0.8×	339 1.3×	81 1.1×	3 0.0×	70	1.2k
Linda K. Han United States	14	82 0.1×	117 0.2×	94 0.4×	151 2.1×	10 0.1×	26	926
Shusuke Yoshikawa Japan	15	218 0.3×	555 1.2×	238 0.9×	170 2.4×	3 0.0×	63	768
Diann Blanset United States	14	719 1.1×	950 2.0×	379 1.4×	58 0.8×		30	1.6k

Countries citing papers authored by J. Charles

Since Specialization

Citations

This map shows the geographic impact of J. Charles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Charles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Charles more than expected).

Fields of papers citing papers by J. Charles

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Charles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Charles. The network helps show where J. Charles may publish in the future.

Co-authorship network of co-authors of J. Charles

This figure shows the co-authorship network connecting the top 25 collaborators of J. Charles. A scholar is included among the top collaborators of J. Charles based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Charles. J. Charles is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mouret, Stéphane, Mylène Pezet, Benoît Roubinet, et al.. (2025). MCT1 lactate transporter blockade re-invigorates anti-tumor immunity through metabolic rewiring of dendritic cells in melanoma. Nature Communications. 16(1). 1083–1083. 18 indexed citations breakdown →

Bellier, Alexandre, et al.. (2024). Outcomes of adjuvant lymph node field radiotherapy and immunotherapy for stage III melanoma. Cancer/Radiothérapie. 28(8). 633–639.

Muñoz‐Couselo, Eva, Henri Montaudié, Miguel‐Ángel Berciano‐Guerrero, et al.. (2024). 1136P Cosibelimab in advanced cutaneous squamous cell carcinoma (CSCC): Longer-term efficacy and safety results from pivotal study. Annals of Oncology. 35. S745–S746. 1 indexed citations

Roubinet, Benoît, Mylène Pezet, Michel Thépaut, et al.. (2023). Melanoma tumour‐derived glycans hijack dendritic cell subsets through C‐type lectin receptor binding. Immunology. 171(2). 286–311. 7 indexed citations

Roubinet, Benoît, Stéphane Mouret, Michel Thépaut, et al.. (2023). The melanoma tumor glyco-code impacts human dendritic cells’ functionality and dictates clinical outcomes. Frontiers in Immunology. 14. 1120434–1120434. 11 indexed citations

Valladeau‐Guilemond, Jenny, Stéphane Mouret, Benoît Roubinet, et al.. (2022). Unique CLR expression patterns on circulating and tumor-infiltrating DC subsets correlated with clinical outcome in melanoma patients. Frontiers in Immunology. 13. 1040600–1040600. 15 indexed citations

Lepelley, Marion, et al.. (2022). Skin cancers under Janus kinase inhibitors: A World Health Organization drug safety database analysis. Therapies. 77(6). 649–656. 21 indexed citations

Dalle, Stéphane, M.‐T. Leccia, Laurent Mortier, et al.. (2021). Late-onset adverse events of anti-PD1 therapy in melanoma patients: An observational study from MELBASE, a nationwide prospective cohort. Journal of the American Academy of Dermatology. 86(2). 345–352. 8 indexed citations

Charles, J., Nicolas Terzi, Carole Schwebel, et al.. (2019). Multi-organ failure induced by Nivolumab in the context of allo-stem cell transplantation. Experimental Hematology and Oncology. 8(1). 8–8. 17 indexed citations

10.

Charles, J., et al.. (2019). Ischémie digitale avec ulcération pulpaire sous ipilimumab. Annales de Dermatologie et de Vénéréologie. 147(3). 212–216. 1 indexed citations

11.

Gobbini, Élisa, et al.. (2019). Current opinions in immune checkpoint inhibitors rechallenge in solid cancers. Critical Reviews in Oncology/Hematology. 144. 102816–102816. 22 indexed citations

12.

Busser, Benoît, S. Moncayo, Florian Trichard, et al.. (2017). Characterization of foreign materials in paraffin-embedded pathological specimens using in situ multi-elemental imaging with laser spectroscopy. Modern Pathology. 31(3). 378–384. 22 indexed citations

13.

Charles, J., et al.. (2014). Deux cas de dermatose acantholytique sous vémurafénib. Annales de Dermatologie et de Vénéréologie. 141(11). 689–693.

14.

Aspord, Caroline, Corinne Leloup, Jean‐Paul Molens, et al.. (2014). Imiquimod Inhibits Melanoma Development by Promoting pDC Cytotoxic Functions and Impeding Tumor Vascularization. Journal of Investigative Dermatology. 134(10). 2551–2561. 60 indexed citations

15.

Aspord, Caroline, M.‐T. Leccia, J. Charles, & Joël Plumas. (2013). Plasmacytoid Dendritic Cells Support Melanoma Progression by Promoting Th2 and Regulatory Immunity through OX40L and ICOSL. Cancer Immunology Research. 1(6). 402–415. 143 indexed citations

16.

Aspord, Caroline, M.‐T. Leccia, Dimitri Salameire, et al.. (2012). HLA-A*0201 Plasmacytoid Dendritic Cells Provide a Cell-Based Immunotherapy for Melanoma Patients. Journal of Investigative Dermatology. 132(10). 2395–2406. 36 indexed citations

17.

Aspord, Caroline, J. Charles, M.‐T. Leccia, et al.. (2011). GENiusVac, une stratégie vaccinale antitumorale innovante basée sur des cellules dendritiques plasmocytoïdes allogéniques. La Revue de Médecine Interne. 32(5). 329–332. 1 indexed citations

18.

Épaulard, Olivier, et al.. (2009). Multiple aggressive squamous cell carcinomas associated with prolonged voriconazole therapy in four immunocompromised patients. Clinical Microbiology and Infection. 16(9). 1362–1364. 32 indexed citations

19.

Salameire, Dimitri, I. Templier, J. Charles, et al.. (2008). An “Anaplastic” Kaposi's Sarcoma Mimicking a Stewart-Treves Syndrome. A Case Report and a Review of Literature. American Journal of Dermatopathology. 30(3). 265–268. 14 indexed citations

20.

Charles, J.. (1978). Lion Murard et Patrick Zilberman, Le petit travailleur infatigable, ou le prolétaire régénéré (Villes — Usines, habitat et intimités au XIXème siècle), Recherches n°25, 1976. Hommes et Terres du Nord. 1(1). 115–116. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact